Diet Drinks vs Water, a GLP-1 Drug Without Muscle Loss, and More-Highlights From ADA 2025

JAMA. 2025 Aug 12;334(6):473-474. doi: 10.1001/jama.2025.10671.
No abstract available

Plain language summary

This Medical News article is an interview with Raveendhara Bannuru, MD, PhD, vice president of medical affairs at the American Diabetes Association, about clinical highlights from the organization’s recent Scientific Sessions.